Year |
Citation |
Score |
2021 |
Diamant G, Simchony Goldman H, Gasri Plotnitsky L, Roitman M, Shiloach T, Globerson-Levin A, Eshhar Z, Haim O, Pencovich N, Grossman R, Ram Z, Volovitz I. T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields. Journal of Immunology (Baltimore, Md. : 1950). PMID 34215656 DOI: 10.4049/jimmunol.2100100 |
0.672 |
|
2019 |
Diamant G, Simchony H, Shiloach T, Globerson-Levin A, Gasri Plotnitsky L, Eshhar Z, Pencovich N, Grossman R, Ram Z, Volovitz I. P12.05 Evaluating the compatibility of tumor treating electric fields with key antitumoral immune functions Neuro-Oncology. 21: iii60-iii60. DOI: 10.1093/neuonc/noz126.216 |
0.667 |
|
2018 |
Zupančič E, Curato C, Kim JS, Yeini E, Porat Z, Viana AS, Globerson-Levin A, Waks T, Eshhar Z, Moreira JN, Satchi-Fainaro R, Eisenbach L, Jung S, Florindo HF. Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29306001 DOI: 10.1016/J.Nano.2017.12.011 |
0.596 |
|
2018 |
Diamant G, Simchony H, Shiloach T, Globerson-Levin A, Eshhar Z, Grossman R, Ram Z, Volovitz I. IMMU-71. EVALUATING THE COMPATIBILITY OF TUMOR TREATING ELECTRIC FIELDS WITH KEY ANTI-TUMORAL T CELL FUNCTIONS Neuro-Oncology. 20: vi137-vi138. DOI: 10.1093/Neuonc/Noy148.574 |
0.609 |
|
2014 |
Globerson-Levin A, Waks T, Eshhar Z. Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1029-38. PMID 24572294 DOI: 10.1038/Mt.2014.28 |
0.65 |
|
Show low-probability matches. |